sexta-feira, 13 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 2, 2026

Tech stocks today: OpenAI strikes deal with Pentagon amid Anthropic feud, Nvidia invests $4B in photonics makers

View original at finance.yahoo.com
Tech stocks today: OpenAI strikes deal with Pentagon amid Anthropic feud, Nvidia invests $4B in photonics makers Artificial intelligence startup OpenAI (OPAI.PVT) said it landed a deal with the Department of Defense over the weekend, coinciding with the US strikes in Iran and coming just after President Trump ordered a…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • CoreWeave capital expenditures will increase from $15.4 billion in 2025 to at least $30 billion in 2026

    80% confidence
  • What we are witnessing is not a temporary squeeze, but a tsunami-like shock originating in the memory supply chain, with ripple effects spreading across the entire consumer electronics industry

    80% confidence
  • Cannot in good conscience accede to Pentagon's request for unrestricted AI model usage

    80% confidence
  • Anthropic would rather cut ties with the government than cross two red lines: using models for mass surveillance of US citizens and using them to develop fully autonomous weapons

    80% confidence
  • Confident in hyperscalers' cash flow growing due to inflection of agentic AI and usefulness of agents across enterprises

    80% confidence
  • This is a simple, common-sense request that will prevent Anthropic from jeopardizing critical military operations and potentially putting our warfighters at risk

    80% confidence
  • Data Center revenue for Q4 was record $62.3 billion, up 75% year-over-year and 22% sequentially, driven by major platform shifts in accelerated computing and AI

    80% confidence
  • Contract language received overnight from DOD made virtually no progress on preventing Claude's use for mass surveillance or fully autonomous weapons, with legalese allowing safeguards to be disregarded

    80% confidence
  • We don't need it, we don't want it, and will not do business with them again

    80% confidence
  • If Anthropic doesn't get their act together and be helpful during phase-out, will use full power of presidency to make them comply with major civil and criminal consequences

    80% confidence
  • OpenAI shares Anthropic's red lines on mass surveillance and autonomous weapons

    80% confidence
  • Computing has fundamentally changed in the age of AI, with software running on intelligence with tokens generated in real time by AI factories

    80% confidence
  • The partnership with OpenAI remains strong and central, with unchanged IP, commercial, revenue-sharing, and AGI processes

    80% confidence
  • DOD has no desire to surveil Americans or develop fully autonomous weapons

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Tech stocks today: OpenAI strikes deal with Pentagon amid Anthropic feud, Nvidia invests $4B in photonics makers — Source | Via News | pt.VIA.NEWS